Clonidine Hydrochloride Tablets — Class II drug recall D-0559-2016
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2016-01-06, distributed in AL. cGMP Deviations
| Recall number | D-0559-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2015-07-10 |
| Classified | 2015-12-31 |
| Reported by FDA | 2016-01-06 |
| Terminated | 2017-03-08 |
| Distributed | AL |
| Quantity | 9 bottles |
| Reason classes | cgmp |
| NDC | 43063-0509-01 |
| Lot numbers | 02/16, B14D26 |
Product
Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0559-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.